Cumberland Pharmaceuticals (CPIX) EBT Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported EBT Margin of 34.36% for Q1 2026, down 4506.0% on a YoY basis from 0.78% in Q1 2025, and down 237.55% sequentially from 10.18% in Q4 2025.
Cumberland Pharmaceuticals (CPIX) EBT Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of EBT Margin data on file, last reported at 34.36% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 4506.0% year-over-year to 34.36%; the trailing twelve-month figure through Mar 2026 stood at 17.17% (down 909.0% YoY), and the FY2025 full-year result was 6.31%, up 1076.0% from the prior year.
- EBT Margin fell to 34.36% in Q1 2026, from 10.18% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 10.7% in Q1 2025 to a low of 67.11% in Q4 2023.
- A 5-year average of 15.08% and a median of 12.49% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 4834 bps in 2024 and tumbled 4506 bps in 2026, its largest moves.
- Tracing CPIX's EBT Margin over 5 years: stood at 26.43% in 2022, then slumped by 154 bps to 67.11% in 2023, then jumped by 72 bps to 18.77% in 2024, then soared by 46 bps to 10.18% in 2025, then slumped by 238 bps to 34.36% in 2026.
- Business Quant data shows CPIX's EBT Margin at 34.36% in Q1 2026, 10.18% in Q4 2025, and 23.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | -34.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.36% |
| Dec 31, 2025 | -10.18% |
| Sep 30, 2025 | -23.44% |
| Jun 30, 2025 | -6.73% |
| Mar 31, 2025 | 10.70% |
| Dec 31, 2024 | -18.77% |
| Sep 30, 2024 | -16.79% |
| Jun 30, 2024 | -11.08% |
| Mar 31, 2024 | -22.25% |
| Dec 31, 2023 | -67.11% |
| Sep 30, 2023 | -10.47% |
| Jun 30, 2023 | 7.98% |
| Mar 31, 2023 | 1.94% |
| Dec 31, 2022 | -26.43% |
| Sep 30, 2022 | -3.65% |
| Jun 30, 2022 | -13.18% |
| Mar 31, 2022 | -12.49% |
| Dec 31, 2021 | -52.59% |
| Sep 30, 2021 | -19.52% |
| Jun 30, 2021 | 8.09% |